Expand CTOR Menu
CTOR MENU

CTOR Latest Press Releases

-- June 1, 2026 --

Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies PRNewswire 7:00 AM

-- May 26, 2026 --

Citius Oncology Announces Presentation of LYMPHIR Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting PRNewswire 8:00 AM

-- May 15, 2026 --

Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update PRNewswire 4:30 PM
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update PRNewswire 4:30 PM

-- April 29, 2026 --

Citius Oncology Ships First International Order of LYMPHIR to Europe PRNewswire 8:00 AM

-- March 31, 2026 --

Citius Oncology Provides Commercial Update on LYMPHIR Launch Highlighting Early Adoption and Expanding Clinical Development PRNewswire 9:11 AM

-- March 24, 2026 --

Citius Oncology to Participate in USCLC Annual Workshop 2026, Highlighting LYMPHIR in Discussions with Leading Cutaneous Lymphoma Experts PRNewswire 8:00 AM

-- March 10, 2026 --

Citius Oncology Announces Positive Topline Results from Investigator-Initiated Phase 1 Study of LYMPHIR in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers PRNewswire 8:47 AM

-- March 4, 2026 --

Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR (E7777) Dosing Prior to Commercial CAR-T Therapy in High-Risk Diffuse Large B-Cell Lymphoma PRNewswire 9:15 AM

-- February 13, 2026 --

Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR PRNewswire 8:00 AM
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR PRNewswire 8:00 AM

-- February 11, 2026 --

Citius Oncology Expands International Distribution of LYMPHIR to European Union Through Exclusive Agreement with Uniphar PRNewswire 8:00 AM
Market Data Delayed 15 Minutes